Department of Molecular Pharmacology

Overview

Recent News

Molecular Pharmacology NewsNews | Pompe’s Circumstance
Dr. Jeffrey Pessin has been awarded $2.5 million from the National Institute of Arthritis and Musculoskeletal and Skin Diseases to study the mechanism of Pompe’s disease. ...more

Molecular Pharmacology NewsNews | Hypothalamus and Aging - Brain Region May Hold Key
While the search continues for the Fountain of Youth, researchers may have found the body’s “fountain of aging”: the brain region known as the hypothalamus. For the first time, scientists at Albert Einstein College of Medicine of Yeshiva University report that the hypothalamus of mice controls aging throughout the body. Their discovery of a specific age-related signaling pathway opens up new strategies for combating diseases of old age and extending lifespan. The paper was published today in the online edition of Nature....more

Events

Thursday, May 23, 2013 | 12:00 PM
Einstein Internal Faculty Seminar: Dr. Susan Horwitz TBA
Forchheimer Medical Science Building, 5th. Fl. Lecture Hall

Friday, June 07, 2013 | 12:00 PM
Work In Progress: Jaclyn LoPiccolo TBA
Forchheimer Medical Science Building, 253N

view calendar

Molecular Pharmacology offers unique training in signal transduction and the molecular basis of drug action. Research in the Department is broad, and includes programs focused on cell and gene regulation, hormone action and biogenesis, caveolae, protein and phosphoinositide kinases and phosphatases, glycoproteins and lectins, drug resistance and the development of activators, inhibitors and drugs. The Department has specialized research facilities including:

  1. A Chemical – Biology Laboratory that performs high throughput screens for novel drugs and specific inhibitors (activators) of signal transduction pathways and
  2. A Biodefense Proteomics Research Center whose goal is to identify and validate chemotherapeutic targets in protozoal parasites.

All students have access to institutional research cores such as, state-of-the-art mass spectrometry, image analysis, and transgenic and knock-out mouse technologies.

 

Target diseases studied in Molecular Pharmacology include: cancer, cardiac and thyroid pathogenesis, diabetes and muscular dystrophy. Research programs in the department train Ph.D. students for independent research careers as well as other options. Students will present their research at national meetings, conferences and symposia.The department has 19 faculty members and a cadre of 43 graduate students, postdoctoral fellows, Instructors and Associates, who participate in departmental activities. Numerous scientific collaborations are in process within the Department. This provides students with interactions with multiple faculty members, thus creating a diverse, dynamic scientific environment. 

The department sponsors a Monday seminar series for visiting scientists that enables students to engage in dialogs with distinguished extramural investigators. Journal clubs, Friday Work-In-Progress research meetings, a weekly department-wide seminar and a Wednesday afternoon "happy hour" promote scientific and social interactions among the students, fellows and faculty. Graduates of the Department of Molecular Pharmacology are typically placed in postdoctoral positions in outstanding laboratories and have been the recipients of prestigious fellowships. Many of our Ph.D. graduates have permanent positions in universities, biotechnology/pharmaceutical companies, and government laboratories at the National Institutes of Health and the Food and Drug Administration. The Department is proud of the accomplishments of its graduates and welcomes new students to join us at a time of great potential and progress in science.

Click here to log in